ACROUD AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.764 SEK | -10.12% |
|
-19.41% | -59.79% |
| Feb. 22 | Transcript : Acroud AB, 2023 Earnings Call, Feb 22, 2024 | |
| Feb. 22 | Acroud AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The stock, which is currently worth 2023 to 0.58 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company has insufficient levels of profitability.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Casinos & Gaming
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -59.79% | 13.72M | C- | ||
| +18.08% | 36.8B | B | ||
| -2.14% | 23.41B | C+ | ||
| -9.49% | 23.12B | B- | ||
| -9.41% | 22.11B | A | ||
| +24.74% | 21.3B | D | ||
| +15.12% | 19.84B | B- | ||
| -0.23% | 9.95B | C- | ||
| +5.37% | 7.67B | - | ||
| -25.23% | 7.56B | B- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
- Stock Market
- Equities
- ACROUD Stock
- Ratings Acroud AB